Two Sigma Advisers
CDAK

Two Sigma Advisers’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Two Sigma Advisers’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,600
Closed -$5.41K – 2810
2022
Q4 		$5.41K Buy
+13,600
New +$5.41K ﹤0.01% 2475